Fig. 7
From: CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
CD146 predicted poor prognosis of HCC patients. a Patients in comparative CD146 high group (n = 62) had higher recurrence rate than those in comparative CD146 low group (n = 58) (P <0.001). b patients in comparative CD146 high group (n = 62) had lower overall survival time than those in comparative CD146 low group (n = 58) (P < 0.001)